Replies to post #155925 on NorthWest Biotherapeutics Inc (NWBO)

[Rootjim]

LessIsMore your name seems to indicate your a short. Anyway as far as warrants are concerned. If they were all exercised, it would put over 200 million dollars cash into NWBO bank. Creating a strong balance sheet for NWBO
As far as dilution goes this has been difficult for all involved.There is light at the end of the tunnel. An example of a dollar stock would be PCLN. It had a reverse split of 7 to 1. Putting the stock at about seven dollars per share. Then went onto hundreds of dollars per share. NWBO is in a bigger market.
For now the best thing to do is wait for NWBO publication in a Major peer review Journal. IMO

[sentiment_stocks]

I'm hoping the posters who like to shout out unrealistic daily or weekly share price targets will start to take accountability for their failed predictions.

Why on earth would that give you such satisfaction?

Most of the time, any "shout outs" on the board as to how how we are going or how low are within a few pennies (e.g. we are at .31 and someone might predict .34 - big whoop). I suppose if you were trading the stock with large sums of money, a few pennies could make a difference (it certainly does change my holdings in dollars total every time it moves up or down a penny). But if that's what you are doing (trading), why does it bother you so much what anyone predicts on this board?

Thank you for your predictions with your analysis behind them. It's always interesting to read what others think might happen and why. And please note, there are plenty of others on this board that also do the same thing. You are not the only one.

[evanstony]

Interesting conviction on company value.

My take on both 1 & 2 of your reasons rely on a small or non existent increase in value for the future worth of the proprietary vaccines and applications. The extension of life for 25% plus of the cancer patients will IMO increase the value of NWBO from a low $150 Million plus or minus with all warrants at today's price to $2 Billion dollars plus... If 35% OS is achieved add significantly more.

Seeing the interim Blinded data, #3, will definitely show results of a life extension or it will not. IMO reading the tidbits of released data from last year indicate an improvement of 50% over SOC which means more than 36 months OS and many passing 60 months.

My hope is two fold. Help for cancer patients and LP stays the course and we do not have a BO but grow to serve patients. Surviving this long has already been miraculous. With good results the next phase seems not nearly as difficult.

[Barunuuk]

Depends on the blinded data. If the median OS from the blinded data comes in at >=22 months, I think that will and could be a game changer. I actually think it will come in close to 24 months.

Anything above 22 months will attract the eye of wall street investors, and that in a self could be huge. With KITE & JUNO already cashing in on the Immunotherapy excitement, and with this being soooooo undersold, (even with the diluted shares), it could easily push this over $1.

With 450 Million shares (assuming all warrants, all shares, everything), a $10B market cap (where KITE & JUNO were bought out at), gives a share price of $4